Eating disorders Genetics and mental health Personality disorders 
Psychiatric Times
JUNE 23, 2025
1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.
Psychiatric Times
JULY 1, 2025
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Health care professionals should monitor the child’s growth and development and provide necessary interventions to mitigate weight loss.” FDA Drug Safety Communication.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Psychiatric Times
JUNE 23, 2025
Overview of Attention Deficit/Hyperactivity Disorder EP: 2. Role of Pediatricians in Diagnosing ADHD ADHD risk factors encompass both genetic and environmental components that significantly impact child development. ADHD in Elementary School Age Child: Patient Case 1 EP: 3. ADHD Diagnosis Criteria EP: 4. Risk Factors for ADHD EP: 7.
Psychiatric Times
JUNE 30, 2025
Both medications carry important safety considerations including potential for increased suicidal ideation, requiring careful monitoring and education about distinguishing medication-related intrusive thoughts from situational mental health concerns. Subscribe Now!
Psychiatric Times
JUNE 30, 2025
Related Videos Related Content Advertisement June 17th 2025 ADHD With Bipolar Disorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!
Psychiatric Times
JUNE 23, 2025
Before reaching specialized behavioral health services, families typically consult pediatricians who must possess comprehensive knowledge of ADHD presentation, diagnostic criteria, and evidence-based treatment approaches. Subscribe Now!
Psychiatric Times
JUNE 18, 2025
Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. The DSM-5 task force concluded that there was not enough evidence to justify incorporating APS as an official mental disorder diagnosis in Section II.
Expert insights. Personalized for you.
95 
Let's personalize your content